How ChrysCapital’s partial exit from drugmaker panned out

By Ankit Doshi

  • 08 Nov 2019
Premium
Credit: VCCircle

ChrysCapital has sold another chunk of its stake in a Mumbai-based drugmaker, as the homegrown private equity firm positions itself to exit the seven-year-old investment by taking advantage of a buoyant stock market. The PE firm recently sold 1.2 million shares, or nearly a 1% stake, in Ipca Laboratories Ltd through ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.